BTYNB is a potent and selective inhibitor of IMP1 binding to c-Myc mRNA (IC50=5 µM). BTYNB exhibits selectivity and effectiveness against IMP1-postive cancer cell lines. BTYNB can be used for cancer research[1].
Molecular Weight:
309.18
Purity:
98
CAS Number:
[304456-62-0]
Formula:
C12H9BrN2OS
Target:
c-Myc
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted